GRAIL's NHS-Galleri Trial Results From ASCO 2026

Professor Richard Neal, MBChB, PhD, Co-Chief Investigator of the NHS-Galleri trial, reveals clinically meaningful findings presented at the 2026 ASCO Annual Meeting from the first prospective, randomized controlled trial evaluating a multi-cancer early detection (MCED) test in population screening. More information: http://bit.ly/4uEu0U5 Learn more: https://grail.com https://galleri.com Galleri should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. Rx only. See Important Safety Information: http://bit.ly/33m8pFa